The blog
Short, practical notes on the day-to-day logistics of peptide protocols — GLP-1 titration, cold chain, COA reading, injection technique, vendor pricing. New posts twice a day.
Latest posts
Verifying an online peptide pharmacy's license
Before buying online, verify license, accreditation, and 503A/B status. The four checks that separate legitimate from grey-market.
Within-region vs across-region injection rotation
Insulin needs within-region rotation; weekly GLP-1 has more flexibility. The two strategies and when each applies.
Weekly weight + 4-week moving average on GLP-1
Daily weight swings 2–4 lb from fluid alone. Weekly fasted weight with 4-week moving average is the signal you can act on.
Why home body-fat scales drift on GLP-1
Bioimpedance scales measure resistance through tissue, not actual fat. Hydration changes during GLP-1 use can move the reading 3–5% day to day.
BPC-157 dosing windows: does plasma half-life matter?
BPC-157's plasma half-life is very short, but the tissue effect may persist longer. What this means for once-daily vs split-daily dosing.
What to actually log in a peptide-tracking app
Seven categories that matter for any peptide protocol. What's essential, what's noise, and how to use the data.
mcg vs mg: why writing "mcg" prevents misreads
A simple writing convention that prevents 1,000× peptide-dose errors. Why the pharmacy world standardized on "mcg" over "µg".
Skytrofa: 6-month room-temperature HGH cartridges
PEG-conjugated weekly HGH that lives at room temperature for 6 months. The chemistry behind the convenience.
Spotting counterfeit Ozempic pens
Counterfeit pens have hospitalized users. Ten features to check — packaging, labeling, dial mechanism, batch tracking.
Gallbladder disease on GLP-1: the 76-trial meta-analysis
~50% relative-risk increase across 76 trials. The modifiable factors (dose, duration, rate of weight loss) and what to watch for.
Bruising after peptide injection: normal vs hematoma
A small bruise is normal; a hematoma is technique or anatomy. The differences and how to fix the technique side.
Survodutide and mazdutide: GLP-1/glucagon duals
Two Phase-3 GLP-1/glucagon dual agonists with strong liver-fat reduction. Where each fits in the developing pipeline.
Why most peptide therapies stay injectable
Three GI barriers make oral peptides impractical. The rare workarounds — SNAC, small molecules, sublingual — and what changes when they work.
Hypoglycemia on GLP-1 + insulin or sulfonylurea
GLP-1s alone rarely cause hypoglycemia. Combined with insulin or SUs, the risk is real and adjustable. How to monitor.
Reconstitution math: how diluent volume controls concentration
The amount of diluent you add directly controls per-dose volume. The math, the standard setups, and the syringe-precision tradeoff.
EU vs US peptide storage labels
Same molecule, different labeled temperature ranges. EU 22–25 °C vs US 59–86 °F — and what this means when you travel with a pen.
BPC-157 oral vs injectable bioavailability
Oral works for the gut; injectable works systemically. The bioavailability data and what each route can deliver.
Tell anesthesia about your GLP-1 before surgery
Anesthesia teams now routinely ask about GLP-1 use. Why aspiration risk is real, what to disclose, and when to hold the dose.
Upper-arm GLP-1 injection: why you usually need a helper
The posterior arm is a labeled GLP-1 site but tricky to self-inject. When to use the arm, technique, and the helper case.
Liraglutide vs semaglutide: daily vs weekly
Liraglutide half-life is 13 hours, semaglutide's is 165. The tradeoffs of each cadence and when daily is the right choice.
Salt forms: semaglutide acetate vs free acid
Different salt forms have different solubility, stability, and bioavailability. Why compounded supply quality depends on which form is used.
GLP-1 diarrhea: normal vs dehydrating
Loose stool in week 1 is normal. Watery diarrhea for 5+ days is dehydrating and not. The red flags and the hydration math.
IU vs mg: 1 IU insulin = 0.0347 mg — per-drug conversions
IU is biological activity, not mass. Each drug has its own conversion factor. The traps when switching between unit conventions.
Reconstituted peptide shelf life: BAC water vs saline
BAC water gives 28 days of intermittent multi-dose use; saline gives 24 hours. The chemistry behind each — and what to log.
Orforglipron: the small-molecule GLP-1 that isn't a peptide
A non-peptide GLP-1 in tablet form. No SNAC, no 30-minute fast, no injection. Phase 3 data and what changes when oral GLP-1 becomes practical.
Reflux and GERD on GLP-1
GLP-1 reflux is mechanical: slow stomach emptying meeting a normal lower esophageal sphincter. The meal-pattern fix.
Needle reuse causes lipodystrophy even on weekly injections
A blunt, burred reused needle damages tissue more than a fresh needle — and the damage compounds even at one injection per week.
CagriSema REDEFINE: amylin plus semaglutide beats semaglutide alone
Cagrilintide + semaglutide in one weekly injection. Phase 3 numbers and what amylin agonism adds beyond GLP-1.
TB-500 vs Thymosin Beta-4: the naming, explained
TB-500 is marketed as "synthetic TB-4" but it's usually a 7-residue active fragment, not the full 43-residue protein. Why the difference matters.
GLP-1 constipation: the second-phase shift after the nausea
GLP-1 GI side effects shift. Weeks 1–4 are nausea; months 2–6 are constipation. Why, and what to do.
Reading peptide vial labels: 5 mg/0.5 mL ≠ what you think
A vial labeled "5 mg/0.5 mL" delivers 10 mg/mL — twice what people assume. The label-format trap and how to read every variant.
Heat above 86 °F: hour-by-hour peptide degradation
A pen left in a 100 °F car loses measurable activity within hours. The degradation curve and what counts as salvageable.
"Research use only" is not a legal disclaimer
What the label actually means, what it protects, and what it doesn't — both for sellers and for the people who buy from them.
Fat vs muscle loss on GLP-1: what the STEP substudies show
DXA-measured body composition in the semaglutide pivotal trials. The fat-to-lean ratio and what tilts it.
Why insulin cares about sites and weekly GLP-1 barely does
Same subq tissue, very different absorption stories. The half-life math behind the difference — and what it means for rotation.
SURPASS-2: tirzepatide vs semaglutide head-to-head
The trial that put both drugs in the same room. HbA1c reductions, weight loss, side-effect rates — and the caveats.
SNAC: the oral-semaglutide absorption enhancer
The small molecule that lets a 31-residue peptide cross the stomach wall. Mechanism, limits, and the 30-minute rule it enforces.
Resistance training during GLP-1: how to block muscle loss
Without lifting, ~25–35% of weight lost on GLP-1 is muscle. Two sessions a week of the right movements cuts that to under 10%.
U-500 insulin: why FDA mandates special syringes
U-500 insulin is 5× more concentrated than U-100. The dedicated syringe is the only safe interface. The history behind the rule.
Freezing peptides is irreversible
A frozen and thawed pen looks fine, but ice crystals have mechanically disrupted the protein. Why warming doesn't restore potency.
BPC-157 reconstitution: which diluent, how much, why
BAC water vs saline, target concentration, draw math. The full protocol from lyophilized powder to syringe.
GLP-1 nausea peaks weeks 1–4 after each dose bump
Nausea follows the same 4-week curve every titration step. The peaks, the plateau, and when to stop worrying.
Compounded semaglutide concentration errors
The gap between an Ozempic pen and a compounded vial. How concentration confusion hospitalizes patients — and the math to prevent it.
Retatrutide Phase 3: 32% vs tirzepatide's 21%
Retatrutide adds glucagon to the GIP/GLP-1 stack. The Phase 2 numbers were already startling; Phase 3 follow-ups extend the curve.
Abdomen-quadrant rotation map for weekly GLP-1
A clean 8-zone rotation so a once-weekly pen user never injects the same patch twice in 2 months.
Hitting 1.2–1.5 g/kg protein on GLP-1
The muscle-preservation protein target, the per-meal math, and the foods that actually deliver it when meals shrink.
U-100 syringes show volume, not mass
"10 units" on a U-100 syringe is a volume mark, not a mass. The two-step conversion every peptide user should be able to do in their head.
Semaglutide 56-day vs tirzepatide 21-day room-temperature limit
A semaglutide pen tolerates 56 days at room temperature; a tirzepatide pen only 21. The chemistry behind the gap and the practical fix.
Oral semaglutide: the empty-stomach 30-minute rule
Oral semaglutide's bioavailability collapses if you eat or drink within 30 minutes. Why the rule exists, and the cost of breaking it.
Eat protein first on GLP-1: how to use shrinking meals
When fullness arrives after 4–6 bites, those bites have to deliver the protein. The shrinking-meal protein-first protocol.
FDA warnings on BPC-157 and TB-500: immunogenicity and other risks
The FDA has flagged both peptides for immunogenicity risk and incomplete safety data. What the agency actually said and how to read it.
Why tirzepatide beats semaglutide: GIP receptor explained
The 5-point body-weight gap between Wegovy and Zepbound traces back to one extra receptor. What GIP does, and why dual agonism is more than additive.
FDA 2026: end of 503B-bulk semaglutide and tirzepatide
The FDA's 2026 decision to exclude semaglutide and tirzepatide from outsourcing-facility bulk lists ends most legal large-scale compounding. What this means.
Missed-dose rules: Ozempic vs Mounjaro vs Wegovy
Three GLP-1 brands, three different rescue windows. Ozempic 5 days, Mounjaro 4 days, Wegovy 2 days — and what to do when each one slips.
Lipohypertrophy: why insulin absorption gets unpredictable
Lumpy, thickened tissue from repeated injections at the same site changes how your dose absorbs — by 20–30%. What it looks like and how to fix it.
Why a slower semaglutide titration reduces nausea
The 0.25 → 2.4 mg ladder is conservative for a reason. Slower bumps let the gut adapt and roughly halve peak-week nausea.
mg vs mL: the 1,000× peptide dosing error
The single most common peptide overdose comes from confusing mass with volume. The unit-literacy check that catches it before you inject.
Does reconstituted Tirzepatide need to stay cold in transit?
The 2–8 °C rule vs real-world transit conditions. What degrades, how fast, and the FRIO / insulated-pouch thresholds that actually matter.
Why your BPC-157 turned cloudy (and what it means)
Five causes of cloudy reconstituted BPC-157 — from temperature shock to bacterial contamination — and which are still usable.
Can you mix BPC-157 and TB-500 in the same syringe?
The compatibility question for the most common healing stack. Why mixing is usually fine, the two cases it isn't, and the math to do it safely.
How to split a subq peptide dose across two sites
When splitting makes sense (large volumes, injection-site reactions, lipohypertrophy avoidance) and the technique that keeps kinetics intact.
What happens if you skip a Semaglutide dose
The 5-day rule, when to resume at the same dose, when to titrate back down, and why restarting the escalation accidentally is the common mistake.
Reading a COA: what 98% purity actually means
The math behind a HPLC purity number, what the remaining 2% usually is, and why 98% on one vendor's COA is not the same as 98% on another's.
Why peptide pricing varies 5× between vendors
Same compound, same purity claim, a fivefold spread. What is actually driving the price — and which pricing tiers are worth paying for.
Peptide travel: 2026 country-by-country customs rundown
Tactical 2026 snapshot: US, UK, EU, Canada, Australia, Japan, UAE, Singapore. Enforcement posture, airline rules, and a pre-trip checklist.
Related reading
Pillar guides
The eight long-form guides: reconstitution, injection sites, storage, syringe units, first-timer, half-lives, travel, COA.
Peptide glossary
29+ peptides with mechanism, dosing, half-life, side effects, stacks, citations.
Free tools
Reconstitution calculator, dose converter, half-life visualizer.
Track every dose in one place
Peptide Protocol logs every injection, tracks inventory, computes your plasma concentration, and flags site rotations.
Get the iPhone app →